Polymers additives in whole blood are known to modify blood physical properties. For example, Dextran molecules usually accelerate the aggregation of re-suspended RBCs in Ringer solutions. In this work, we first investigate the effect of polymers such as Dextran, PEG (polyethylene glycol) and PVP (polyvinyl propylene) on the aggregation of RBCs directly in whole blood. We find that Dextran does not promote the aggregation in whole blood (at the opposite of re-suspended RBCs in Ringer solutions), which PEG and PVP achieve. In a second step, we make use of the aggregative properties of PEG and PVP to boost plasma separation from whole blood. The approach is based on a faster sedimentation rate of RBCs aggregated by the polymers.
Journal: TechConnect Briefs
Volume: 3, Biotech, Biomaterials and Biomedical: TechConnect Briefs 2017
Published: May 14, 2017
Pages: 138 - 141
Industry sectors: Medical & Biotech | Sensors, MEMS, Electronics
Topics: Micro & Bio Fluidics, Lab-on-Chip